Alifrangis M - Search Results

1

Prevalence of Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment for malaria in Uganda.

Mbonye AK, Birungi J, Yanow SK, Shokoples S, Malamba S, Alifrangis M, Magnussen P. Mbonye AK, et al. Among authors: alifrangis m. Antimicrob Agents Chemother. 2015 Sep;59(9):5475-82. doi: 10.1128/AAC.00507-15. Epub 2015 Jun 29. Antimicrob Agents Chemother. 2015. PMID: 26124154 Free PMC article.

2

Pyrimethamine/sulfadoxine combination in the treatment of uncomplicated falciparum malaria: relation between dihydropteroate synthase/dihydrofolate reductase genotypes, sulfadoxine plasma levels, and treatment outcome.

Khalil I, Alifrangis M, Rønn AM, Gabar HA, Jelinek T, Satti GM, Bygbjerg IC. Khalil I, et al. Among authors: alifrangis m. Am J Trop Med Hyg. 2002 Sep;67(3):225-9. doi: 10.4269/ajtmh.2002.67.225. Am J Trop Med Hyg. 2002. PMID: 12408659

3

Dihydrofolate reductase and dihydropteroate synthase genotypes associated with in vitro resistance of Plasmodium falciparum to pyrimethamine, trimethoprim, sulfadoxine, and sulfamethoxazole.

Khalil I, Rønn AM, Alifrangis M, Gabar HA, Satti GM, Bygbjerg IC. Khalil I, et al. Among authors: alifrangis m. Am J Trop Med Hyg. 2003 May;68(5):586-9. doi: 10.4269/ajtmh.2003.68.586. Am J Trop Med Hyg. 2003. PMID: 12812351

4

Increasing prevalence of wildtypes in the dihydrofolate reductase gene of Plasmodium falciparum in an area with high levels of sulfadoxine/pyrimethamine resistance after introduction of treated bed nets.

Alifrangis M, Lemnge MM, Rønn AM, Segeja MD, Magesa SM, Khalil IF, Bygbjerg IC. Alifrangis M, et al. Am J Trop Med Hyg. 2003 Sep;69(3):238-43. Am J Trop Med Hyg. 2003. PMID: 14628937

5

Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity.

Alifrangis M, Enosse S, Khalil IF, Tarimo DS, Lemnge MM, Thompson R, Bygbjerg IC, Rønn AM. Alifrangis M, et al. Am J Trop Med Hyg. 2003 Dec;69(6):601-6. Am J Trop Med Hyg. 2003. PMID: 14740875

6

A simple, high-throughput method to detect Plasmodium falciparum single nucleotide polymorphisms in the dihydrofolate reductase, dihydropteroate synthase, and P. falciparum chloroquine resistance transporter genes using polymerase chain reaction- and enzyme-linked immunosorbent assay-based technology.

Alifrangis M, Enosse S, Pearce R, Drakeley C, Roper C, Khalil IF, Nkya WM, Rønn AM, Theander TG, Bygbjerg IC. Alifrangis M, et al. Am J Trop Med Hyg. 2005 Feb;72(2):155-62. Am J Trop Med Hyg. 2005. PMID: 15741552 Free article.

7

Response of Plasmodium falciparum to cotrimoxazole therapy: relationship with plasma drug concentrations and dihydrofolate reductase and dihydropteroate synthase genotypes.

Khalil IF, Rønn AM, Alifrangis M, Gabar HA, Jelinek T, Satti GM, Bygbjerg IC. Khalil IF, et al. Among authors: alifrangis m. Am J Trop Med Hyg. 2005 Jul;73(1):174-7. Am J Trop Med Hyg. 2005. PMID: 16014854 Clinical Trial.

8

Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania.

Alifrangis M, Dalgaard MB, Lusingu JP, Vestergaard LS, Staalsoe T, Jensen AT, Enevold A, Rønn AM, Khalil IF, Warhurst DC, Lemnge MM, Theander TG, Bygbjerg IC. Alifrangis M, et al. J Infect Dis. 2006 Jun 15;193(12):1738-41. doi: 10.1086/504269. Epub 2006 May 4. J Infect Dis. 2006. PMID: 16703518

9

Island-wide diversity in single nucleotide polymorphisms of the Plasmodium vivax dihydrofolate reductase and dihydropteroate synthetase genes in Sri Lanka.

Schousboe ML, Rajakaruna RS, Salanti A, Hapuarachchi HC, Galappaththy GN, Bygbjerg IC, Amerasinghe PH, Konradsen F, Alifrangis M. Schousboe ML, et al. Among authors: alifrangis m. Malar J. 2007 Mar 9;6:28. doi: 10.1186/1475-2875-6-28. Malar J. 2007. PMID: 17349045 Free PMC article.

10

Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate.

Shekalaghe S, Drakeley C, Gosling R, Ndaro A, van Meegeren M, Enevold A, Alifrangis M, Mosha F, Sauerwein R, Bousema T. Shekalaghe S, et al. Among authors: alifrangis m. PLoS One. 2007 Oct 10;2(10):e1023. doi: 10.1371/journal.pone.0001023. PLoS One. 2007. PMID: 17925871 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters